Chinook_yahoo_711x400.jpg
Aduro Biotech Announces First Quarter 2015 Financial Results
28 mai 2015 16h00 HE | Chinook Therapeutics, Inc.
Established major $750M collaboration with Novartis for STING in oncology Strengthened cash position with $200M upfront payment from Novartis and $149.3M in net proceeds from IPO and...